This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study design
The Swedish lifestyle modification study (Eriksson et al, 1991) , Long et al 1994 study, and the Melbourne study were non-randomised controlled trials with concurrent controls. The duration of the follow up in the Swedish study was 5 years. The corresponding figure in the Long study was 4.8 years. The rate of loss to follow up in the Swedish study was 2/41 in the NIDDM group; 20/181 in the intervention-IGT group; and 23/79 in the control-IGT group.
Analysis of effectiveness
It was not specified whether the analysis of the effectiveness results in each study was based on intention to treat or on treatment completers only. The key health outcomes in the Swedish study were weight loss at 5-year follow-up, fitness after 5 years (as measured by oxygen uptake), and the transition probabilities to different health states. The two IGT study groups were comparable in most parameters. The clinical outcome in the Long study was incidence of NIDDM (percentper annum). The change in BMI at 10 years follow-up (fell, no change, or increased) was the main health outcome in the Melbourne study.
Effectiveness results
Results for the NIDDM, intervention-IGT, control-IGT, and control-NGT groups were:
Weight loss at 5-year follow-up: -2.0, -3.3, +0.2, and +2.0kg, (P<0.0001);
Fitness score: +14.5, +10.0, -4.9, and -9.0, P<0.03 for NIDDM and P<0.002 for IGT).
Transition rates after 5 years to NIDDM, IGT, and NIG state were:
For the NIDDM group: 46.2%, 30.7%, and 21.1%;
For the intervention-IGT: 10.6%, 37.3%, and 52.2%;
For the control-IGT group: 21.4%, 42.8%, and 35.7%;
For the control-NGT: 0, 7.1%, and 93%.
The incidence of NIDDM (% pa) was 0.15 for the intervention group versus 4.7 for the control group. Based on the results of the Long study and other studies, the five year transfer matrices for the surgical intervention were calculated.
The percentage of patients with gestational diabetes who experienced a fall inBMI whilst in the IGT or NGT group (n=145) was 89% against 11% for patients who developed NIDDM (n=50) (reference category). The corresponding percentages for the "no change in BMI" category were 73% and 27%, respectively (odd ratio, 2.91; 95% CI: 1.01 -8.41). The corresponding values for the "increased" category were 67% and 33%, respectively (odd ratio, 3.85; 95% CI: 1.49 -9.99). The transition matrices for this strategy were computed based on the results of the Melbourne study.
Clinical conclusions
The Swedish and Long studies revealed the effectiveness of the respective interventions in the primary prevention of NIDDM compared with normal care.
Modelling
A Markov model was employed to represent the expected progression between the health states of NIDDM, IGT, and NGT in order ultimately to estimate the cost-effectiveness of alternative programmes. Transition probabilities were estimated for each programme. The time period adopted in the transfer matrices was 5 years.
Outcomes assessed in the review
In the work place programme for males, the annual mortality, adjusted by metabolic state and applied for the successful participants in the intervention group,and the annual mortality adjusted for over-weight and applied for the unsuccessful participants in the intervention and control groups, were among the outcomes assessed in the review. Post-operative mortality and the effectiveness of bariatric surgery in terms of successful weight loss were among the other outcomes assessed.
Study designs and other criteria for inclusion in the review
Not reported.
Sources searched to identify primary studies
Criteria used to ensure the validity of primary studies
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Methods of combining primary studies
Investigation of differences between primary studies
Not reported. In the workplace programme for males, the annual mortality adjusted by metabolic state (% per annum) and applied for the successful participants in the intervention group ranged from 0.55 for participants aged 45-49 years with NIDDM to 2.32 for participants aged 65-70 years with NGT; the annual mortality adjusted for over-weight (rr=1.2) (% per annum) and applied for the unsuccessful participants in the intervention and control groups varied from 0.66 for participants aged 45-49 years with NIDDM to 2.78 for participants aged 65-70 years with NGT. Post-operative mortality and the effectiveness of bariatric surgery in terms of successful weight loss were 1% and 87%, respectively.
Results of the review

Methods used to derive estimates of effectiveness
Estimates of effectiveness were also derived from expert opinions.
Estimates of effectiveness and key assumptions
The transition probabilities for the intervention group in workplace behavioural overweight males was assumed to be 0.010, 0.040 and 0.950 for the transition from NGT state to NIDDM, IGT, and NGT state, respectively. The corresponding values for the control group were 0.950, 0.040, 0.010. The value for the transition from NGT to NIDDM for the control group was 0.010. The assumed success rate and reduction in incidence of NIDDM for the workplace programme were 33% and 50%, respectively. The corresponding values for the intensive diet/behavioural programme for seriously obese and previous gestational diabetes were 33% and 70%-30%, and 33% and 50%, respectively. The success rate of the media-based programme was assumed to be 1% (0.1% in the sensitivity analysis) with a 50% rate of reduction in the incidence of NIDDM. In the GP-based programme, it was assumed that 20% of patients would achieve modest weight reduction/fitness enhancement; the successful intervention group was assumed to experience a 12.5% reduction in incidence of NIDDM. The success rate and reduction in incidence of NIDDM for the bariatric surgery were assumed to be 87% and 85%, respectively.
Measure of benefits used in the economic analysis
The measure of benefits used in the economic analysis were diabetes years prevented and life years gained. The benefit results per 100 participants were reported for two target populations, a population of persons with IGT and a mixed population (90% NGT and 10% IGT).
Direct costs
Costs were discounted. The resource quantities were not reported separately from the costs. The cost items included in each programme were reported separately. The programme costs were included in the cost analysis. The resource requirements of each programme in terms of natural units were estimated using the programme descriptions. The unit cost data were obtained from the published literature and were applied to the resource requirements of each programme in order to compute the programme costs. The cost calculations were performed from the perspective of a health care system. The price data referred to 1993-95. Expected health service savings due to general reduction in cardiovascular disease risk were not accounted for in the cost analysis. The costs of morbidity caused by surgery were not included in the cost analysis.
